Logo image of BMRC

BANK OF MARIN BANCORP/CA (BMRC) Stock Fundamental Analysis

NASDAQ:BMRC - Nasdaq - US0634251021 - Common Stock - Currency: USD

25.33  -0.5 (-1.94%)

After market: 25.33 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BMRC. BMRC was compared to 394 industry peers in the Banks industry. The financial health of BMRC is average, but there are quite some concerns on its profitability. BMRC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BMRC had positive earnings in the past year.
BMRC had a positive operating cash flow in the past year.
BMRC had positive earnings in 4 of the past 5 years.
In the past 5 years BMRC always reported a positive cash flow from operatings.
BMRC Yearly Net Income VS EBIT VS OCF VS FCFBMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.17%, BMRC is doing worse than 92.39% of the companies in the same industry.
BMRC has a worse Return On Equity (-1.47%) than 92.64% of its industry peers.
Industry RankSector Rank
ROA -0.17%
ROE -1.47%
ROIC N/A
ROA(3y)0.47%
ROA(5y)0.65%
ROE(3y)4.64%
ROE(5y)5.94%
ROIC(3y)N/A
ROIC(5y)N/A
BMRC Yearly ROA, ROE, ROICBMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

BMRC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMRC Yearly Profit, Operating, Gross MarginsBMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

4

2. Health

2.1 Basic Checks

BMRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BMRC has been reduced compared to 1 year ago.
The number of shares outstanding for BMRC has been increased compared to 5 years ago.
The debt/assets ratio for BMRC has been reduced compared to a year ago.
BMRC Yearly Shares OutstandingBMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BMRC Yearly Total Debt VS Total AssetsBMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

BMRC has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.00, BMRC belongs to the top of the industry, outperforming 90.86% of the companies in the same industry.
BMRC has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
BMRC has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. BMRC outperforms 88.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC17.14%
BMRC Yearly LT Debt VS Equity VS FCFBMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BMRC Yearly Current Assets VS Current LiabilitesBMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

5

3. Growth

3.1 Past

BMRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.89%, which is quite impressive.
Measured over the past years, BMRC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.42% on average per year.
The Revenue for BMRC has decreased by -24.61% in the past year. This is quite bad
Measured over the past years, BMRC shows a decrease in Revenue. The Revenue has been decreasing by -6.90% on average per year.
EPS 1Y (TTM)22.89%
EPS 3Y-29.7%
EPS 5Y-18.42%
EPS Q2Q%66.67%
Revenue 1Y (TTM)-24.61%
Revenue growth 3Y-13.96%
Revenue growth 5Y-6.9%
Sales Q2Q%9.92%

3.2 Future

Based on estimates for the next years, BMRC will show a very strong growth in Earnings Per Share. The EPS will grow by 44.69% on average per year.
BMRC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.56% yearly.
EPS Next Y68%
EPS Next 2Y44.69%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.56%
Revenue Next 2Y11.56%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BMRC Yearly Revenue VS EstimatesBMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
BMRC Yearly EPS VS EstimatesBMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.83, BMRC is valued on the expensive side.
83.50% of the companies in the same industry are cheaper than BMRC, based on the Price/Earnings ratio.
BMRC is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
BMRC is valuated correctly with a Price/Forward Earnings ratio of 13.44.
Based on the Price/Forward Earnings ratio, BMRC is valued a bit more expensive than the industry average as 70.30% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, BMRC is valued rather cheaply.
Industry RankSector Rank
PE 24.83
Fwd PE 13.44
BMRC Price Earnings VS Forward Price EarningsBMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BMRC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 14.52
EV/EBITDA N/A
BMRC Per share dataBMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BMRC's earnings are expected to grow with 44.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y44.69%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

BMRC has a Yearly Dividend Yield of 3.87%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.31, BMRC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, BMRC pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.87%

5.2 History

The dividend of BMRC has a limited annual growth rate of 4.66%.
BMRC has been paying a dividend for at least 10 years, so it has a reliable track record.
BMRC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)4.66%
Div Incr Years0
Div Non Decr Years19
BMRC Yearly Dividends per shareBMRC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of BMRC are negative and hence is the payout ratio. BMRC will probably not be able to sustain this dividend level.
The dividend of BMRC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-250.66%
EPS Next 2Y44.69%
EPS Next 3YN/A
BMRC Yearly Income VS Free CF VS DividendBMRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

BANK OF MARIN BANCORP/CA

NASDAQ:BMRC (7/11/2025, 8:00:02 PM)

After market: 25.33 0 (0%)

25.33

-0.5 (-1.94%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-28 2025-04-28/bmo
Earnings (Next)07-28 2025-07-28/bmo
Inst Owners60.98%
Inst Owner Change-0.02%
Ins Owners8.88%
Ins Owner Change13.78%
Market Cap410.85M
Analysts81.67
Price Target24.89 (-1.74%)
Short Float %3.97%
Short Ratio5.5
Dividend
Industry RankSector Rank
Dividend Yield 3.87%
Yearly Dividend1
Dividend Growth(5Y)4.66%
DP-250.66%
Div Incr Years0
Div Non Decr Years19
Ex-Date05-08 2025-05-08 (0.25)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.18%
Min EPS beat(2)-6.63%
Max EPS beat(2)14.98%
EPS beat(4)2
Avg EPS beat(4)-13.62%
Min EPS beat(4)-66.42%
Max EPS beat(4)14.98%
EPS beat(8)3
Avg EPS beat(8)-26.07%
EPS beat(12)5
Avg EPS beat(12)-18.02%
EPS beat(16)8
Avg EPS beat(16)-3.57%
Revenue beat(2)0
Avg Revenue beat(2)-5.79%
Min Revenue beat(2)-6.4%
Max Revenue beat(2)-5.18%
Revenue beat(4)0
Avg Revenue beat(4)-4.9%
Min Revenue beat(4)-6.4%
Max Revenue beat(4)-3.52%
Revenue beat(8)0
Avg Revenue beat(8)-6.23%
Revenue beat(12)3
Avg Revenue beat(12)-2.57%
Revenue beat(16)7
Avg Revenue beat(16)0.08%
PT rev (1m)0%
PT rev (3m)-14.08%
EPS NQ rev (1m)-0.53%
EPS NQ rev (3m)-4.32%
EPS NY rev (1m)3.17%
EPS NY rev (3m)-2.52%
Revenue NQ rev (1m)-6.32%
Revenue NQ rev (3m)-2.1%
Revenue NY rev (1m)-5.36%
Revenue NY rev (3m)-1.66%
Valuation
Industry RankSector Rank
PE 24.83
Fwd PE 13.44
P/S 5.43
P/FCF 14.52
P/OCF 14.18
P/B 0.93
P/tB 1.13
EV/EBITDA N/A
EPS(TTM)1.02
EY4.03%
EPS(NY)1.88
Fwd EY7.44%
FCF(TTM)1.74
FCFY6.89%
OCF(TTM)1.79
OCFY7.05%
SpS4.67
BVpS27.1
TBVpS22.46
PEG (NY)0.37
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.17%
ROE -1.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 37.4%
ROA(3y)0.47%
ROA(5y)0.65%
ROE(3y)4.64%
ROE(5y)5.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 28.63%
Cap/Sales 0.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC17.14%
ROIC/WACCN/A
Cap/Depr(3y)46.73%
Cap/Depr(5y)41.79%
Cap/Sales(3y)1.32%
Cap/Sales(5y)1.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.89%
EPS 3Y-29.7%
EPS 5Y-18.42%
EPS Q2Q%66.67%
EPS Next Y68%
EPS Next 2Y44.69%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.61%
Revenue growth 3Y-13.96%
Revenue growth 5Y-6.9%
Sales Q2Q%9.92%
Revenue Next Year12.56%
Revenue Next 2Y11.56%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47.26%
FCF growth 3Y-14.28%
FCF growth 5Y-7.17%
OCF growth 1Y-49.38%
OCF growth 3Y-14.42%
OCF growth 5Y-7.07%